Actuate Therapeutics Inc (ACTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 5,435 | 7,773 | 0 | 6,476 | 5,584 |
| Operating Income | -5,435 | -7,773 | N/A | -6,476 | -5,584 |
| Interest Expense | 5 | 5 | 0 | 5 | 5 |
| Other Income | -1,132 | -518 | 0 | 143 | 65 |
| Pre-tax Income | -6,572 | -8,296 | 0 | -6,338 | -5,524 |
| Net Income Continuous | -6,572 | -8,296 | N/A | -6,338 | -5,524 |
| Net Income | $-6,572 | $-8,296 | $N/A | $-6,338 | $-5,524 |
| EPS Basic Total Ops | -4.20 | -5.40 | N/A | -4.31 | -3.88 |
| EPS Basic Continuous Ops | -4.20 | -5.40 | N/A | -4.31 | -3.88 |
| EPS Diluted Total Ops | -4.20 | -5.40 | N/A | -4.31 | -3.88 |
| EPS Diluted Continuous Ops | -4.20 | -5.40 | N/A | -4.31 | -3.88 |
| EPS Diluted Before Non-Recurring Items | -4.20 | -5.40 | N/A | N/A | N/A |
| EBITDA(a) | $-5,435 | $-7,773 | $N/A | $-6,476 | $-5,584 |